These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6172115)

  • 21. [Prevention of dextran anaphylaxis using hapten dextran].
    Comberg HU
    Dtsch Med Wochenschr; 1984 Jan; 109(1):36-8. PubMed ID: 6198137
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anaphylaxis following administration of Rheomacrodex].
    Pocsay G; Papp S; Velösy B; Bányai T
    Orv Hetil; 1985 Jun; 126(26):1587-9. PubMed ID: 2410848
    [No Abstract]   [Full Text] [Related]  

  • 23. [Death caused by infusion of low-molecular dextran].
    Plamieniak L; Kowal-Gierczak B; Kotschy M; Kurzawska M; Kozlowska B
    Wiad Lek; 1974 May; 27(10):901-5. PubMed ID: 4839858
    [No Abstract]   [Full Text] [Related]  

  • 24. [Death from anaphylactic shock in polyglucin transfusion].
    Ruban GE
    Sud Med Ekspert; 1981; 24(2):57. PubMed ID: 6166106
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. I. A Scandinavian multicenter study on the effects of 10 ml dextran 1, 15% administered before dextran 70 or dextran 40.
    Ljungström KG; Renck H; Hedin H; Richter W; Rosberg B
    Acta Chir Scand; 1983; 149(4):341-8. PubMed ID: 6193665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anaphylactic shock due to dextrans].
    Daniliuk TV; Il'in VIu; Rubanovich GL
    Klin Med (Mosk); 1980 Jun; 58(6):57-9. PubMed ID: 6157051
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anaphylactic shock after administering rheopolyglucin].
    Borodavko SF
    Klin Khir (1962); 1983 Jan; (1):54-5. PubMed ID: 6187965
    [No Abstract]   [Full Text] [Related]  

  • 28. [Undesirable effects of macromolecules].
    Hint H
    Anesth Analg (Paris); 1976; 3(4):703-7. PubMed ID: 1015656
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of dextran anaphylaxis. Ten years experience with hapten dextran.
    Hedin H; Ljungström KG
    Int Arch Allergy Immunol; 1997; 113(1-3):358-9. PubMed ID: 9130577
    [No Abstract]   [Full Text] [Related]  

  • 30. [Report of the month: blood and blood substitution].
    Med Monatsschr; 1974 Jan; 28(1):1-3. PubMed ID: 4208928
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blood coagulation changes due to repeated infusions of plasma substitutes].
    Müller KH; Scholz HJ; Barthel R
    Geburtshilfe Frauenheilkd; 1969 Dec; 29(12):1095-100. PubMed ID: 5405166
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of allergic dextran reactions by premedication of 20 ml hapten in 12,000 patients in Switzerland].
    Gruber UF; Wettler H; Allemann U; Gerber H; Laubenthal H; Messmer K
    Schweiz Rundsch Med Prax; 1983 Feb; 72(8):269-70. PubMed ID: 6188142
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of dextran-induced anaphylactoid reactions by hapten inhibition.
    Edwards AM; Holland A
    Lancet; 1980 Jun; 1(8181):1307. PubMed ID: 6155580
    [No Abstract]   [Full Text] [Related]  

  • 34. [Posttransfusion reactions to the use of blood substitutes].
    Shabalin VN; Litmanovich KIu; Sabel'nikov VV
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):39-45. PubMed ID: 6185943
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute oligoanuric renal failure in dextran 40 treated patients.
    Frey L; Messmer K
    Ren Fail; 1998 May; 20(3):543-5. PubMed ID: 9606743
    [No Abstract]   [Full Text] [Related]  

  • 36. [Usefulness and hazards of blood volume replacement therapy].
    Gruber UF
    Internist (Berl); 1982 Aug; 23(8):450-6. PubMed ID: 6182121
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dextran-induced anaphylactoid reactions in two patients with gastrointestinal cancer].
    Miyamoto Y; Tashiro C
    Masui; 1996 Apr; 45(4):500-3. PubMed ID: 8725611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Impact and complications observed in the use of macromolecules].
    Laxenaire MC; Moneret-Vautrin D; Sigiel M; Jacob F; Picard JM
    Anesth Analg (Paris); 1976; 3(4):691-702. PubMed ID: 65135
    [No Abstract]   [Full Text] [Related]  

  • 39. [Macrodex/Rheomacrodex. Prevention of adverse effects].
    Ljungström KG; Ulseth E; Lilleaasen P
    Tidsskr Nor Laegeforen; 1986 Jan; 106(2):129-31. PubMed ID: 2420021
    [No Abstract]   [Full Text] [Related]  

  • 40. Hapten resistant dextran induced ARDS reaction following intracoronary stent deployment.
    Gossman DE; Schneider F
    Cathet Cardiovasc Diagn; 1996 May; 38(1):56-61. PubMed ID: 8722859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.